BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 24314926)

  • 1. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach.
    McIntyre RS; Filteau MJ; Martin L; Patry S; Carvalho A; Cha DS; Barakat M; Miguelez M
    J Affect Disord; 2014 Mar; 156():1-7. PubMed ID: 24314926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.
    Tundo A; de Filippis R; Proietti L
    World J Psychiatry; 2015 Sep; 5(3):330-41. PubMed ID: 26425446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?
    Dodd S; Bauer M; Carvalho AF; Eyre H; Fava M; Kasper S; Kennedy SH; Khoo JP; Lopez Jaramillo C; Malhi GS; McIntyre RS; Mitchell PB; Castro AMP; Ratheesh A; Severus E; Suppes T; Trivedi MH; Thase ME; Yatham LN; Young AH; Berk M
    World J Biol Psychiatry; 2021 Sep; 22(7):483-494. PubMed ID: 33289425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of trauma-focused psychotherapies in treatment-resistant depression (TRD) in-patients: A randomized, controlled pilot-study.
    Minelli A; Zampieri E; Sacco C; Bazzanella R; Mezzetti N; Tessari E; Barlati S; Bortolomasi M
    Psychiatry Res; 2019 Mar; 273():567-574. PubMed ID: 30711853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The integrative management of treatment-resistant depression: a comprehensive review and perspectives.
    Carvalho AF; Berk M; Hyphantis TN; McIntyre RS
    Psychother Psychosom; 2014; 83(2):70-88. PubMed ID: 24458008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mindfulness-based cognitive therapy (MBCT) versus the health-enhancement program (HEP) for adults with treatment-resistant depression: a randomized control trial study protocol.
    Eisendrath SJ; Gillung EP; Delucchi KL; Chartier M; Mathalon DH; Sullivan JC; Segal ZV; Feldman MD
    BMC Complement Altern Med; 2014 Mar; 14():95. PubMed ID: 24612825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and acceptability of adjunctive psychological and pharmacological interventions for treatment-resistant depression: protocol for a systematic review and network meta-analysis.
    Husain MI; Strawbridge R; Carter B; Jones BDM; Young A; Carvalho AF
    BMJ Open; 2019 May; 9(5):e028538. PubMed ID: 31092667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape.
    Jha MK; Mathew SJ
    Am J Psychiatry; 2023 Mar; 180(3):190-199. PubMed ID: 36855876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges of Treatment-resistant Depression.
    Pandarakalam JP
    Psychiatr Danub; 2018 Sep; 30(3):273-284. PubMed ID: 30267518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Pre-existing Conditions Relevant for Adverse Events and Potential Drug-Drug Interactions Associated with Augmentation Therapies Among Patients with Treatment-Resistant Depression.
    Zhdanava M; Karkare S; Pilon D; Joshi K; Rossi C; Morrison L; Sheehan J; Lefebvre P; Lopena O; Citrome L
    Adv Ther; 2021 Sep; 38(9):4900-4916. PubMed ID: 34368919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annual Research Review: Defining and treating pediatric treatment-resistant depression.
    Dwyer JB; Stringaris A; Brent DA; Bloch MH
    J Child Psychol Psychiatry; 2020 Mar; 61(3):312-332. PubMed ID: 32020643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A New Prediction Model for Evaluating Treatment-Resistant Depression.
    Kautzky A; Baldinger-Melich P; Kranz GS; Vanicek T; Souery D; Montgomery S; Mendlewicz J; Zohar J; Serretti A; Lanzenberger R; Kasper S
    J Clin Psychiatry; 2017 Feb; 78(2):215-222. PubMed ID: 28068461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions.
    McIntyre RS; Alsuwaidan M; Baune BT; Berk M; Demyttenaere K; Goldberg JF; Gorwood P; Ho R; Kasper S; Kennedy SH; Ly-Uson J; Mansur RB; McAllister-Williams RH; Murrough JW; Nemeroff CB; Nierenberg AA; Rosenblat JD; Sanacora G; Schatzberg AF; Shelton R; Stahl SM; Trivedi MH; Vieta E; Vinberg M; Williams N; Young AH; Maj M
    World Psychiatry; 2023 Oct; 22(3):394-412. PubMed ID: 37713549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation with Atypical Antipsychotics for Treatment-Resistant Depression.
    Cantù F; Ciappolino V; Enrico P; Moltrasio C; Delvecchio G; Brambilla P
    J Affect Disord; 2021 Feb; 280(Pt A):45-53. PubMed ID: 33202337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy and tolerability of pharmacological and somatic interventions in adult patients with treatment-resistant depression: a systematic review and network meta-analysis.
    Papadimitropoulou K; Vossen C; Karabis A; Donatti C; Kubitz N
    Curr Med Res Opin; 2017 Apr; 33(4):701-711. PubMed ID: 28035869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hidden third: improving outcome in treatment-resistant depression.
    Schlaepfer TE; Agren H; Monteleone P; Gasto C; Pitchot W; Rouillon F; Nutt DJ; Kasper S
    J Psychopharmacol; 2012 May; 26(5):587-602. PubMed ID: 22236505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective chart review study to quantify the monthly medical resource use and costs of treating patients with treatment resistant depression in the United Kingdom.
    Denee T; Ming T; Waller J; Bailey T; Rajkovic-Hooley O; Middleton-Dalby C; Le HH; Zhang Q; McCrone P; Taylor D
    Curr Med Res Opin; 2021 Feb; 37(2):311-319. PubMed ID: 33253055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining treatment-resistant depression.
    Gaynes BN; Lux L; Gartlehner G; Asher G; Forman-Hoffman V; Green J; Boland E; Weber RP; Randolph C; Bann C; Coker-Schwimmer E; Viswanathan M; Lohr KN
    Depress Anxiety; 2020 Feb; 37(2):134-145. PubMed ID: 31638723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can Machine Learning help us in dealing with treatment resistant depression? A review.
    Pigoni A; Delvecchio G; Madonna D; Bressi C; Soares J; Brambilla P
    J Affect Disord; 2019 Dec; 259():21-26. PubMed ID: 31437696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
    Thomas SJ; Shin M; McInnis MG; Bostwick JR
    Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.